Barry Frankel

Barry R.
Frankel is the founder of Sedor Pharmaceuticals LLC.
Mr. Frankel is currently a Director at Galenica Pharmaceuticals, Inc. Mr. Frankel was a Director at SyntheMed, Inc. from 2003 to 2011.
Mr. Frankel was a Director at Molecular Insight Pharmaceuticals, Inc. Mr. Frankel was a Director at Inspiration Biopharmaceuticals, Inc. Mr. Frankel was Managing Director at BioDevelopment Ventures.
Mr. Frankel was Managing Director at The Frankel Group Associates LLC from 2011 to 2013.
Mr. Frankel was a Director at bioAffinity Technologies, Inc. from 2015 to 2018.
Mr. Frankel was an Investment Research Officer at Citibank NA (New York).
Mr. Frankel was President at S.J.
Weinstein Associates, Inc. from 1982 to 1993.
Mr. Frankel earned an MBA degree from the University of Pennsylvania in 1974.
Mr. Frankel earned an undergraduate degree from Rutgers State University of New Jersey in 1972.